List of articles with "Leap Therapeutics"

Cypherpunk Technologies Q3 Update

Cypherpunk Technologies Q3 Update

USA Cambridge Leap Therapeutics Zcash Cypherpunk Technologies
Leap Becomes Cypherpunk

Leap Becomes Cypherpunk

USA Cambridge Leap Therapeutics Cypherpunk Zcash
Leap Therapeutics DeFianCe Results

Leap Therapeutics DeFianCe Results

United States Cambridge Leap Therapeutics Sirexatamab DeFianCe Study
Leap Therapeutics Secures Funding

Leap Therapeutics Secures Funding

United States Cambridge Leap Therapeutics Digital Asset Winklevoss Capital
Leap Therapeutics Funding

Leap Therapeutics Funding

United States Cambridge Digital Assets Leap Therapeutics Winklevoss Capital
Leap Therapeutics at ESMO 2025

Leap Therapeutics at ESMO 2025

USA Cambridge Leap Therapeutics ESMO Congress DKK1 antibody
Leap Therapeutics Q2 2025

Leap Therapeutics Q2 2025

United States Cambridge Immuno-Oncology Leap Therapeutics DKN-01
Leap Therapeutics Update

Leap Therapeutics Update

United States Cambridge Leap Therapeutics Sirexatamab DeFianCe Study
Leap's Q1 2025 Results

Leap's Q1 2025 Results

USA Cambridge Leap Therapeutics DKN-01 FL-501
Leap's FL-501 Insights

Leap's FL-501 Insights

United States Chicago Leap Therapeutics FL-501 GDF-15
Virtual Event on Sirexatamab

Virtual Event on Sirexatamab

USA Cambridge Leap Therapeutics Sirexatamab Advanced CRC
Leap Therapeutics Update

Leap Therapeutics Update

United States Cambridge Clinical Trials Leap Therapeutics DKN-01
Leap Therapeutics Update

Leap Therapeutics Update

United States Cambridge Colorectal Cancer Leap Therapeutics Sirexatamab
Leap at J.P. Morgan

Leap at J.P. Morgan

United States San Francisco Immuno-Oncology Leap Therapeutics DKN-01

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.